Key Clinical Evidence Phase 2 Randomized Trial in Obesity (48 weeks) Jastreboff AM et al., New England Journal of Medicine, 2023 ClinicalTrials.gov: NCT04881760 The Phase 2 study evaluated multiple doses of retatrutide versus placebo over 48 weeks
FIGURE 3 Low bioavailability remains a major hurdle for harnessing the therapeutic benefits of PCs, necessitating innovative delivery approaches such as nano-encapsulation, phospholipid complexation, and co-administration with permeability enhancers
L-Karnitinin Faydalar Ya Kaybna Yardmc Olur : Supports weight-management programs, but is not a magic fat burner: A 2016 systematic review and meta-analysis of randomized controlled trials found that adults taking carnitine lost about 1.33 kg more body weight than placebo on average
We work closely with each patient to develop realistic and achievable goals that fit their lifestyle and long-term health objectives
Ingredients Acetyl-L-carnitine hydrochloride, coating agent hydroxypropyl methylcellulose Important information: Food supplements should not be used as a substitute for a balanced and varied diet and a healthy lifestyle
Additionally, Bhat et al., reported that a high-fat/high-cholesterol diet can promote cognitive decline and brain dysfunction [156]
